Random population-wide genetic damage induced in replicating cells treated with methotrexate

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 413, Issue 3, 1998, Pages 251-264

  Chow, Ming ^a   Koo, John ^a   Ng, Patrick ^a   Rubin, Harry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Cancer chemotherapy; Clastogen; Mutation

Indexed keywords

ADENINE; CLASTOGEN; FOLINIC ACID; METHOTREXATE; THYMIDINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL BIOLOGY; GENETIC DAMAGE; GROWTH RATE; HERITABILITY; LETHALITY; MOUSE; MUTATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

3T3 CELLS; ADENINE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL CYCLE; CULTURE MEDIA; DNA DAMAGE; FOLIC ACID ANTAGONISTS; HYPOXANTHINE; METHOTREXATE; MICE; MUTAGENICITY TESTS; THYMIDINE;

ANIMALIA; CICONIIFORMES;

EID: 0032579750     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00025-4     Document Type: Article

References (38)

1. Sinclair W.K. X-ray-induced heritable damage (small colony formation) in cultured mammalian cells. Radiat. Res. 21:1964;584-611.
2. Todd P. Defective mammalian cells isolated from x-irradiated cultures. Mutat. Res. 5:1968;173-178.
3. Chang W.P., Little J.B. Delayed reproductive death in x-irradiated Chinese hamster ovary cells. Int. J. Radiat. Biol. 60:1991;483-496.
4. Puck T.T. Gamma-ray mutagenesis measurement in mammalian cells. Mutat. Res. 329:1995;173-181.
5. Puck T.T., Johnson R., Rasmussen S. A system for mutation measurement in mammalian cells: Application to gamma-irradiation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1218-1223.
6. Rubin H., Chow M., Yao A. Cellular aging, destabilization and cancer. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1825-1830.
7. Rubin H., Yao A., Chow M. Heritable, population-wide damage to cells as the driving force of neoplastic transformation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4843-4847.
8. Chow M., Rubin H. Ubiquitous, heritable damage in cell populations that survive treatment with methotrexate. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8773-8778.
9. Jainchill J.L., Aaronson S.A., Todaro G.J. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:1969;549-553.
10. Rubin A.L., Arnstein P., Rubin H. Physiological induction and reversal of focus formation and tumorigenicity in NIH-3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 87:1990;10005-10009.
11. Rubin H., Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1860-1864.
12. Shipley G.D., Ham R.G. Improved medium and culture conditions for clonal growth with minimum serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro. 17:1981;656-670.
13. Borsa J., Whitmore G.F. Cell killing studies on the mode of action of methotrexate on L-cells in vitro. Cancer Res. 29:1969;731-744.
14. Hakala M.T., Taylor E. The ability of purine and thymidine derivatives and of glycine to support the growth of mammalian cells in culture. J. Biol. Chem. 234:1959;126-128.
15. Matherly L.H., Fry D.W., Goldman I.D. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Erlich ascites tumoir cells in vitro. Cancer Res. 43:1983;2694-2699.
16. Matherly L.H., Barlowe C.K., Goldman I.D. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Cancer Res. 46:1986;588-593.
17. Johnson L.F., Fuhrman C.L., Abelson H.T. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity. Cancer Res. 38:1978;2408-2412.
18. Branda R.F., McCormack J.J., Perlmutter C.A., Mathews L.A., Robison S.H. Effects of folate deficiency on the metastatic potential of murine melanoma cells. Cancer Res. 48:1988;4529-4534.
19. Li J.C., Kaminskas E. Accumulation of DNA strand breaks and methotrexate toxicity. Proc. Natl. Acad. Sci. U.S.A. 81:1984;5694-5698.
20. Lorico A., Toffoli G., Boiocchi M., Erba E., Broggini M., Rappa G., D'Incalci M. Accumulation of DNA strand breaks in cells exposed to methotrexate or N-10-propargyl-5,8-dideazafolic acid. Cancer Res. 48:1988;2036-2041.
21. Jacky P.B., Beek B., Sutherland G.R. Fragile sites in chromosomes: possible model for the study of spontaneous chromosome breakage. Science. 220:1983;69-70.
22. Chang W.P., Little J.B. Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving x-irradiation: association with delayed reproductive death phenotype. Mutat. Res. 270:1992;191-199.
23. Chang W.P., Little J.R. Evidence that DNA double strand breaks initiate the phenotype of delayed reproductive death in Chinese hamster ovary cells. Radiat. Res. 131:1992;53-59.
24. Frank J.P., Williams J.R. X-ray induction of persistent hypersensitivity to mutation. Science. 216:1982;307-308.
25. Bostock C.J., Tyler-Smith C. Gene amplification in methotrexate resistant mouse cells: II. Rearrangement and amplification of non-dihydrofolate reductase gene sequences accompanying chromosomal changes. J. Mol. Biol. 153:1981;219-236.
26. -/- mutants early in their clonal history. Mutat. Res. 147:1985;237-242.
27. Sutherland G.R. The fragile x chromosome. Int. Rev. Cytol. 81:1983;107-143.
28. Hryniuk W.M., Fischer G.A., Bertino J.R. S-phase cells of rapidly growing and resting populations. Differences in response to methotrexate. Mol. Pharmacol. 5:1969;557-564.
29. ± mouse lymphoma mutagen system. Mutat. Res. 59:1979;61-108.
30. ± mouse lymphoma cells. Mutat. Res. 151:1985;147-159.
31. Thacker J. The nature of mutants induced by ionizing radiation in cultured hamster cells: III. Molecular characterization of HPRT-deficient mutants induced by X-rays or A particles showing that the majority have deletions of all or part of the hprt gene. Mutat. Res. 160:1989;267-275.
32. Evans H.H. The prevalence of multilocus lesions in radiation-induced mutants. Radiat. Res. 137:1994;131-144.
33. Liber H.L., Yandell D.W., Little J.B. A comparison of mutation induction at the tk and hprt loci in human lymphoblastoid cells; quantitative differences are due to an additional class of mutations at the autosomal tk locus. Mutat. Res. 216:1989;9-17.
34. Sutherland G.R. Heritable fragile sites on human chromosomes: I. Factors affecting expression in lymphocyte culture. Am. J. Hum. Genet. 31:1979;125-135.
35. Smith V., Chou K.H., Lashkari D., Botstein D., Brown P.O. Functional analysis of yeast chromosome V by genetic footprinting. Science. 274:1996;2069-2074.
36. Barry M.A., Behnke C.A., Eustman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:1990;2353-2362.
37. Kaufmann S.H. Induction of endonucleocytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:1989;5870-5878.
38. Kung A.L., Zetterberg A., Sherwood S.W., Schimke R.T. Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res. 50:1990;7307-7317.